Lifestyle interventions for knee pain in overweight and obese adults aged ≥45: Economic evaluation of randomised controlled trial

BMJ (Online)

Volumn 339, Issue 7721, 2009, Pages 610-612

  Barton, Garry R ^a   Sach, Tracey H ^a,b,c   Jenkinson, Claire ^b   Doherty, Michael ^b   Avery, Anthony J ^b   Muir, Kenneth R ^b  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DIET THERAPY; DRUG COST; ECONOMIC ASPECT; FEMALE; GENERAL PRACTICE; GROUPS BY AGE; HEALTH SERVICE; HUMAN; KNEE PAIN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MUSCLE EXERCISE; MUSCLE TRAINING; OBESITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROBABILITY; PROFESSIONAL PRACTICE; QUADRICEPS FEMORIS MUSCLE; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; UNITED KINGDOM; AGED; ARTHRALGIA; BODY MASS; COST BENEFIT ANALYSIS; ECONOMICS; KINESIOTHERAPY; KNEE; MIDDLE AGED; MULTICENTER STUDY; PATIENT EDUCATION; PUBLICATION; TREATMENT OUTCOME;

AGED; ARTHRALGIA; BODY MASS INDEX; COST-BENEFIT ANALYSIS; EXERCISE THERAPY; HUMANS; KNEE JOINT; LIFE STYLE; MIDDLE AGED; OBESITY; OVERWEIGHT; PAMPHLETS; PATIENT EDUCATION AS TOPIC; QUADRICEPS MUSCLE; QUALITY-ADJUSTED LIFE YEARS; TREATMENT OUTCOME;

EID: 70349111477     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.b2273     Document Type: Article

References (28)

1. Jinks C, Jordan K, Ong BN, Croft P. A brief screening tool for knee pain in primary care (KNEST). 2. Results from a survey in the general population aged 50 and over. Rheumatology 2004;43:55-61.
2. Thomas KS, Miller P, Doherty M, Muir KR, Jones AC, O'Reilly SC. Cost effectiveness of a two-year home exercise program for the treatment of knee pain. Arthritis Rheum 2005;53:388-394 (Pubitemid 40799878)
3. Hurley MV, Walsh NE, Mitchell HL, Pimm TJ, Williamson E, Jones RH, et al. Economic evaluation of a rehabilitation program integrating exercise, self-management, and active coping strategies for chronic knee pain. Arthritis Rheum 2007;57:1220-1229 (Pubitemid 47585468)
4. Porcheret M, Jordan K, Jinks C, Croft P, in collaboration with the Primary Care Rheumatology Society. Primary care treatment of knee pain - a survey in older adults. Rheumatology 2007;1694-1700.
5. Porcheret M, Jordan K, Croft P, in collaboration with the Primary Care Rheumatology Society. Treatment of knee pain in older adults in primary care: development of an evidence-based model of care. Rheumatology 2007;46:638-648
6. Messier SP, Loeser RF, Miller GD, Morgan TM, Rejeski WJ, Sevick MA, et al. Exercise and dietary weight loss in overweight and obese older adults with knee osteoarthritis: the arthritis, diet, and activity promotion trial. Arthritis Rheum 2004;50:1501-1510
7. Nevitt MC, Lane N. Body weight and osteoarthritis. Am J Med 1999;107:632-633
8. Thomas KS, Muir KR, Doherty M, Jones AC, O'Reilly SC, Bassey EJ. Home based exercise programme for knee pain and knee osteoarthritis: randomised controlled trial. BMJ 2002;325:752-755 (Pubitemid 35193194)
9. Felson DT, Zhang Y. An update on the epidemiology of knee and hip osteoarthritis with a view to prevention. Arthritis Rheum 1998;41:1343-1355 (Pubitemid 28373113)
10. O'Reilly SC, Jones A, Muir KR, Doherty M. Quadriceps weakness in knee osteoarthritis: the effect on pain and disability. Ann Rheum Dis 1998;56:588-594 (Pubitemid 28513136)
11. Slemenda C, Brandt KD, Heilmam DK, Mazzuca SA, Braunsteing EM, Katz BP, et al. Quadriceps weakness and osteoarthritis of the knee. Ann InternMed 1997;127:97-104.
12. O'Reilly SC, Muir KR, Doherty M. Effectiveness of home exercise on pain and disability from osteoarthritis of the knee: a randomised controlled trial. Ann Rheum Dis 1999;58:15-19 (Pubitemid 29112945)
13. Hay EM, Foster NE, Thomas E, Peat G, Phelan M, Yates HE, et al. Effectiveness of community physiotherapy and enhanced pharmacy review for knee pain in people aged over 55 presenting to primary care: pragmatic randomised trial. BMJ 2006;333:995. (Pubitemid 44764346)
14. Jenkinson CM, Doherty M, Avery AJ, Read A, Taylor M, Sach TH, et al. Effects of dietary intervention and quadriceps strengthening exercises on pain and function in overweight people with knee pain: randomised controlled trial. BMJ 2009 doi:10.1136/bmj.b3170.
15. HM Treasury. The green book appraisal and evaluation in central government. London: Stationery Office, 2003.
16. Curtis L. Unit costs of health and social care. Canterbury: University of Kent: Personal Social Services Research Unit, 2007.
17. Prescribing Support Unit. Prescription cost analysis: England 2006. London: Information Centre, Government Statistical Service, 2007.
18. Schafer JL. Multiple imputation: a primer. Stat Methods Med Res 1999;8:3-15.
19. Manca A, Hawkins N, Sculpher MJ. Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. Health Economics 2005;14:487-496 (Pubitemid 40723857)
20. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988;15:1833-1840 (Pubitemid 19037656)
21. Brooks R. EuroQol: the current state of play. Health Policy 1996;37:53-72.
22. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL. Methods for the economic evaluation of health care programmes. 3rd ed. New York: Oxford University Press, 2005.
23. Dolan P. Modelling valuations for EuroQol health states. Med Care 1997;35:1095-1108 (Pubitemid 127453463)
24. Cantor SB. Cost-effectiveness analysis, extended dominance, and ethics: a quantitative assessment. Med Decis Making 1994;14:259-265
25. Briggs AH, Wonderling DE, Mooney CZ. Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. Health Econ 1997;6:327-340
26. National Institute for Health and Clinical Excellence. Guide to the methods of technology appraisal. London: NICE, 2008.
27. Fenwick E, Claxton K, Sculpher MJ. Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Econ 2001;10:779-787 (Pubitemid 34041389)
28. Barton GR, Briggs AH, Fenwick EA. Optimal cost-effective decisions: the role of the cost-effectiveness acceptability curve (CEAC), cost-effectiveness acceptability frontier (CEAF) and expected value of perfect information (EVPI). Value Health 2008;11:886-897